查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2085476

數位PCR市場：2026-2032年全球市場預測（按產品、技術、檢體類型、應用和最終用戶分類）

Digital PCR Market by Product, Technology, Sample Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，數位 PCR 市場將成長至 150.1 億美元，複合年成長率為 11.84%。

主要市場統計數據
基準年 2025 68.5億美元
預計年份：2026年 75.8億美元
預測年份 2032 150.1億美元
複合年成長率 (%) 11.84%

數位PCR執行摘要

數位PCR技術無需依賴標準曲線即可達到核酸的絕對定量，從而革新了分子分析方式。透過將DNA或RNA樣本分成數千至數百萬個獨立的反應，並應用泊松統計方法，數位PCR提高了檢測低表達標靶、罕見突變、拷貝數變異、微量殘存疾病標記、基因編輯結果以及病原體載量的準確性。

數位PCR領域的變革性變化

數位PCR的發展趨勢正從研究性應用轉向更廣泛的轉化和臨床應用。檢查室優先採用能夠縮短處理時間、支援多重PCR、實現穩健的液滴或吸頭分流、最大限度降低污染風險並提供適用於法規環境的可追溯結果的平台。

人工智慧對數位PCR的累積影響

人工智慧 (AI) 透過改善訊號解讀、分區分類、檢測最佳化和工作流程品管，增強了數位 PCR 技術。 AI 驅動的影像和螢光分析有助於區分真陽性和假陽性結果，檢測異常的分區分佈，監測液滴和反應室的質量，並確保高通量檢查室的一致性。

關鍵區域洞察：全球市場中的數位PCR

北美憑藉其先進的臨床實驗室網路、強大的生物製藥研發基礎設施以及在腫瘤和感染疾病成熟的分子診斷技術，仍然是數位PCR技術應用的領先中心。美國透過其精準醫療項目、CLIA認證的檢查室基礎設施、FDA監管的診斷開發以及聯邦政府廣泛支持的基因組研究，推動該地區的發展勢頭。同時，加拿大則受益於其大學醫院網路、癌症基因組學研究舉措以及公共衛生檢查室能力。

關鍵區域洞察：東協、海灣合作理事會、歐盟、金磚國家、七國集團、北約

東協地區的需求受感染疾病監測、學術研究以及新加坡、泰國、馬來西亞、越南、印尼和菲律賓等國醫院分子檢查室擴建的影響。鑑於登革熱、結核病、肝炎、瘧疾和呼吸道病毒在該地區反覆爆發，高靈敏度核酸定量技術在參考實驗室、感染疾病集體爆發和轉化研​​究中發揮至關重要的戰略作用。

來自主要國家關於數位PCR的見解

美國憑藉其生物技術生態系統、腫瘤學研究、臨床試驗活動以及先進的診斷檢查室，成為數位PCR的主要市場。在加拿大，醫院基因組學、癌症研究網路和公共衛生檢測系統正在推動該技術的應用；而墨西哥和巴西則正在擴展其分子檢測基礎設施，以用於感染疾病、癌症治療和學術研究。在歐洲，英國、德國、法國、義大利和西班牙受益於強大的醫學教育、藥物研發、國家級基因組學活動和專業診斷檢查室；而俄羅斯在感染疾病、農業生物技術和應用分子生物學領域的需求仍然強勁。

為行業領導者提供的實用建議

產業領導者應優先考慮數位PCR具有明顯分析優勢的應用領域。這些領域包括罕見突變檢測、拷貝數變異檢測、微量殘存疾病（MRP）分析、基因治療載體定量、基因組編輯評估、病原體負荷測量、抗生素抗藥性監測以及定序分析參考標準的檢驗。

調查方法

本調查方法結合了資訊來源，包括衛生組織、監管機構、同行評審期刊、專利資料庫、臨床試驗註冊庫、標準化機構、公共採購文件和科學會議論文集。在檢驗資訊來源之前，我們會對其時效性、相關性、方法學品質和一致性進行評估。

結論：數位PCR正在發展成為一種可擴展、高精度的檢測方法。

數位PCR正逐漸成為對靈敏度、準確性、可重複性和絕對定量要求的應用領域中不可或缺的分子技術。其應用範圍正在擴展到腫瘤學、感染疾病、移植監測、生殖遺傳學、細胞和基因治療、食品安全和環境監測等領域。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：數位PCR市場：依產品分類

  • 消耗性試劑
  • 裝置
  • 軟體

第8章：數位PCR市場：依技術分類

  • 基於陣列的數位PCR
  • 液滴式數位PCR
  • 微流體數位PCR

第9章：數位PCR市場：依樣本類型分類

  • 血液樣本
  • 細胞培養樣本
  • 環境樣品
  • 食品樣品
  • 組織樣本

第10章：數位PCR市場：依應用分類

  • 環境測試
  • 食品檢驗
  • 基因篩檢
  • 感染疾病
  • 腫瘤學
  • 植物和動物遺傳學

第11章：數位PCR市場：依最終用戶分類

  • 學術研究機構
  • 受託研究機構
  • 醫院/診斷檢查室
  • 製藥和生物技術公司

第12章：數位PCR市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章：數位PCR市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：數位PCR市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Abbott Laboratories
  • Accumax
  • Agilent Technologies, Inc.
  • Analytik Jena GmbH by Endress+Hauser
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • ELITechGroup by Bruker Corp.
  • Eppendorf AG
  • F. Hoffmann-La Roche Ltd.
  • Fluidigm Corporation
  • JN MedSys
  • Merck Sharp & Dohme Corp.
  • PCR Biosystems Ltd.
  • PerkinElmer, Inc.
  • Precigenome LLC
  • Promega Corporation
  • Qiagen NV
  • RainSure Scientific
  • Roche Holding AG
  • Stem Genomics
  • Stilla Technologies
  • Takara Bio, Inc.
  • Thermo Fisher Scientific Inc.
  • Zymo Research Corp
Product Code: MRR-4348D129FA49

The Digital PCR Market is projected to grow by USD 15.01 billion at a CAGR of 11.84% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 6.85 billion
Estimated Year [2026] USD 7.58 billion
Forecast Year [2032] USD 15.01 billion
CAGR (%) 11.84%

Digital PCR Executive Summary

Digital PCR is reshaping molecular analysis by enabling absolute nucleic acid quantification without reliance on a standard curve. By partitioning a DNA or RNA sample into thousands to millions of independent reactions and applying Poisson statistics, digital PCR improves detection of low-abundance targets, rare variants, copy number changes, minimal residual disease markers, gene-editing outcomes, and pathogen loads.

Demand is supported by the expanding use of precision medicine, liquid biopsy, companion diagnostics, gene therapy quality control, and infectious disease surveillance. Global health agencies continue to document high burdens of cancer, tuberculosis, HIV, antimicrobial resistance, and emerging viral threats, reinforcing the need for highly sensitive, reproducible molecular testing technologies across clinical, biopharmaceutical, academic, food safety, environmental, and public health settings.

Transformative Shifts in the Digital PCR Landscape

The digital PCR landscape is moving from research-centered adoption toward broader translational and clinical utility. Laboratories are prioritizing platforms that reduce hands-on time, support multiplexing, deliver robust droplet or chip partitioning, minimize contamination risk, and provide traceable results suitable for regulated environments.

Transformative shifts include the rise of liquid biopsy workflows for oncology, increasing use of dPCR in cell and gene therapy manufacturing, and growing interest in wastewater and environmental surveillance. Regulatory expectations for analytical validation, data integrity, inter-laboratory comparability, and quality management are also raising the value of standardized reagents, automation-ready systems, reference materials, and validated software.

Cumulative Impact of Artificial Intelligence on Digital PCR

Artificial intelligence is strengthening digital PCR by improving signal interpretation, partition classification, assay optimization, and workflow quality control. AI-enabled image and fluorescence analysis can help distinguish true positives from artifacts, flag abnormal partition distributions, monitor droplet or chamber quality, and support consistency across high-throughput laboratories.

The cumulative impact is operational as well as scientific. Predictive analytics can reduce repeat testing, improve reagent planning, support instrument utilization, and connect dPCR outputs with laboratory information systems. In research and clinical development, AI can support biomarker discovery by integrating dPCR results with sequencing, pathology, treatment response, clinical trial, and real-world evidence datasets.

Key Regional Insights: Digital PCR Across Global Markets

North America remains a major center for digital PCR adoption because of its advanced clinical laboratory networks, strong biopharmaceutical research base, and established use of molecular diagnostics in oncology and infectious disease. The United States drives regional momentum through precision medicine programs, CLIA-certified laboratory infrastructure, FDA-regulated diagnostic development, and extensive federally supported genomics research, while Canada benefits from academic hospital networks, cancer genomics initiatives, and public health laboratory capabilities.

Europe shows steady demand as laboratories adapt to the EU In Vitro Diagnostic Regulation and expand validated molecular workflows in oncology, inherited disease research, and infectious disease monitoring. Asia-Pacific is accelerating through China, Japan, South Korea, India, and Australia, where genomics, cancer testing, reproductive health, biomanufacturing, and public health surveillance continue to expand. Latin America, led by Brazil and Mexico, is strengthening adoption through reference laboratories, academic centers, and infectious disease testing, while the Middle East is building molecular capacity through national genome initiatives, oncology investments, and tertiary-care modernization. Africa is advancing through reference-center infectious disease surveillance, tuberculosis and HIV monitoring, genomic epidemiology, and international public health capacity-building programs.

Key Group Insights: ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN demand is shaped by infectious disease monitoring, academic research, and expanding hospital molecular laboratories in Singapore, Thailand, Malaysia, Vietnam, Indonesia, and the Philippines. The region's recurring dengue, tuberculosis, hepatitis, malaria, and respiratory virus burdens make sensitive nucleic acid quantification strategically important for reference laboratories, outbreak response, and translational research.

The GCC is investing in genomics, oncology, rare disease programs, and advanced diagnostic infrastructure, supporting dPCR use in national health systems and private specialty care. The European Union emphasizes regulatory compliance, cross-border research, and high-quality diagnostics under IVDR, increasing the importance of validated assays and traceable analytical workflows. BRICS countries combine large disease burdens with expanding biotechnology capacity, public health modernization, and growing clinical research activity, while G7 markets lead in clinical validation, reimbursement maturity, regulatory science, and high-end instrumentation. NATO-aligned countries increasingly view molecular surveillance as part of health security, biodefense readiness, and resilience planning for emerging pathogens.

Key Country Insights in Digital PCR

The United States is a leading country market for digital PCR because of its biotechnology ecosystem, oncology research, clinical trial activity, and advanced diagnostic laboratories. Canada supports adoption through hospital-based genomics, cancer research networks, and public health testing capacity, while Mexico and Brazil are expanding molecular testing infrastructure for infectious diseases, cancer care, and academic research. In Europe, the United Kingdom, Germany, France, Italy, and Spain benefit from strong academic medicine, pharmaceutical research, national genomics activity, and specialized diagnostic laboratories, while Russia maintains demand in infectious disease, agricultural biotechnology, and applied molecular biology.

In Asia-Pacific, China is scaling genomics and clinical testing infrastructure, India is expanding molecular diagnostics access across infectious disease and oncology applications, Japan emphasizes high-quality precision medicine and regulated diagnostic workflows, Australia supports translational genomics and public health surveillance, and South Korea combines advanced hospital systems with strong biotechnology and precision oncology capabilities. These countries collectively shape demand for reliable, automated, analytically sensitive, and quality-controlled dPCR platforms that can support both research and regulated testing environments.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize applications where digital PCR has clear analytical advantages: rare mutation detection, copy number variation, minimal residual disease research, gene therapy vector quantification, genome-editing assessment, pathogen load measurement, antimicrobial resistance monitoring, and reference-standard validation for sequencing assays.

Commercial strategies should combine automation, assay standardization, AI-enabled analysis, external quality assessment support, and regulatory-ready documentation. Vendors should partner with cancer centers, reference laboratories, biopharma manufacturers, contract testing organizations, academic consortia, and public health agencies to generate clinical evidence, expand sample-to-answer workflows, improve interoperability, and reduce total cost per actionable result. Regional go-to-market models should reflect reimbursement conditions, laboratory infrastructure, workforce skills, procurement practices, and disease-burden differences.

Research Methodology

The research methodology combines secondary research from verified public sources, including health agencies, regulatory bodies, peer-reviewed journals, patent databases, clinical trial registries, standards organizations, public procurement documents, and scientific conference proceedings. Sources are evaluated for recency, relevance, methodological quality, and consistency before inclusion.

Primary validation is conducted through structured discussions with industry participants, laboratory leaders, distributors, clinicians, public health specialists, and technology experts. Data triangulation is applied across demand indicators, application trends, regulatory developments, technology adoption, quality requirements, regional healthcare investments, and disease-burden evidence to ensure an objective, evidence-based view of the digital PCR market without relying on unsupported estimates or forecasts.

Conclusion: Digital PCR Moves Toward Scalable Precision Testing

Digital PCR is becoming a critical molecular technology for applications requiring sensitivity, precision, reproducibility, and absolute quantification. Its role is expanding across oncology, infectious disease, transplant monitoring, reproductive genetics, cell and gene therapy, food safety, and environmental surveillance.

As automation, AI-enabled analysis, multiplexing, reference materials, and regulated assay development mature, digital PCR is positioned to complement sequencing and quantitative PCR rather than replace them. Organizations that align technology performance, clinical evidence, workflow efficiency, data integrity, and regional access strategies will be best placed to build durable value in precision molecular testing.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Digital PCR Market, by Product

  • 7.1. Consumable Reagents
  • 7.2. Instruments
  • 7.3. Software

8. Digital PCR Market, by Technology

  • 8.1. Array Based Digital PCR
  • 8.2. Droplet Digital PCR
  • 8.3. Microfluidic Digital PCR

9. Digital PCR Market, by Sample Type

  • 9.1. Blood Samples
  • 9.2. Cell Culture Samples
  • 9.3. Environmental Samples
  • 9.4. Food Samples
  • 9.5. Tissue Samples

10. Digital PCR Market, by Application

  • 10.1. Environmental Testing
  • 10.2. Food Testing
  • 10.3. Genetic Screening
  • 10.4. Infectious Disease
  • 10.5. Oncology
  • 10.6. Plant Or Animal Genetics

11. Digital PCR Market, by End User

  • 11.1. Academic & Research Institutes
  • 11.2. Contract Research Organizations
  • 11.3. Hospitals & Diagnostic Laboratories
  • 11.4. Pharmaceutical & Biotech Companies

12. Digital PCR Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Digital PCR Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Digital PCR Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Abbott Laboratories
  • 16.2. Accumax
  • 16.3. Agilent Technologies, Inc.
  • 16.4. Analytik Jena GmbH by Endress+Hauser
  • 16.5. Becton, Dickinson and Company
  • 16.6. Bio-Rad Laboratories, Inc.
  • 16.7. Danaher Corporation
  • 16.8. ELITechGroup by Bruker Corp.
  • 16.9. Eppendorf AG
  • 16.10. F. Hoffmann-La Roche Ltd.
  • 16.11. Fluidigm Corporation
  • 16.12. JN MedSys
  • 16.13. Merck Sharp & Dohme Corp.
  • 16.14. PCR Biosystems Ltd.
  • 16.15. PerkinElmer, Inc.
  • 16.16. Precigenome LLC
  • 16.17. Promega Corporation
  • 16.18. Qiagen N.V.
  • 16.19. RainSure Scientific
  • 16.20. Roche Holding AG
  • 16.21. Stem Genomics
  • 16.22. Stilla Technologies
  • 16.23. Takara Bio, Inc.
  • 16.24. Thermo Fisher Scientific Inc.
  • 16.25. Zymo Research Corp

LIST OF FIGURES

  • FIGURE 1. GLOBAL DIGITAL PCR MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL DIGITAL PCR MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL DIGITAL PCR MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL DIGITAL PCR MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL DIGITAL PCR MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL DIGITAL PCR MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL DIGITAL PCR MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL DIGITAL PCR MARKET SIZE, BY PRODUCT, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL DIGITAL PCR MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL DIGITAL PCR MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL DIGITAL PCR MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL DIGITAL PCR MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL DIGITAL PCR MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL DIGITAL PCR MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL DIGITAL PCR MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL DIGITAL PCR MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL DIGITAL PCR MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL DIGITAL PCR MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL DIGITAL PCR MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL DIGITAL PCR MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL DIGITAL PCR MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL DIGITAL PCR MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL DIGITAL PCR MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL DIGITAL PCR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL DIGITAL PCR MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CONSUMABLE REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CONSUMABLE REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CONSUMABLE REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL DIGITAL PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ARRAY BASED DIGITAL PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ARRAY BASED DIGITAL PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ARRAY BASED DIGITAL PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL DROPLET DIGITAL PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL DROPLET DIGITAL PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL DROPLET DIGITAL PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MICROFLUIDIC DIGITAL PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MICROFLUIDIC DIGITAL PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MICROFLUIDIC DIGITAL PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL DIGITAL PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD SAMPLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD SAMPLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD SAMPLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CELL CULTURE SAMPLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CELL CULTURE SAMPLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CELL CULTURE SAMPLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ENVIRONMENTAL SAMPLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ENVIRONMENTAL SAMPLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ENVIRONMENTAL SAMPLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL FOOD SAMPLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL FOOD SAMPLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL FOOD SAMPLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL TISSUE SAMPLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL TISSUE SAMPLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL TISSUE SAMPLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL DIGITAL PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ENVIRONMENTAL TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ENVIRONMENTAL TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ENVIRONMENTAL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL FOOD TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL FOOD TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL FOOD TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL GENETIC SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL GENETIC SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL GENETIC SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL INFECTIOUS DISEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL INFECTIOUS DISEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL INFECTIOUS DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PLANT OR ANIMAL GENETICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PLANT OR ANIMAL GENETICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PLANT OR ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL DIGITAL PCR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL HOSPITALS & DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL HOSPITALS & DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL HOSPITALS & DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PHARMACEUTICAL & BIOTECH COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PHARMACEUTICAL & BIOTECH COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PHARMACEUTICAL & BIOTECH COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL DIGITAL PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC DIGITAL PCR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC DIGITAL PCR MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC DIGITAL PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC DIGITAL PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC DIGITAL PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC DIGITAL PCR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA DIGITAL PCR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA DIGITAL PCR MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA DIGITAL PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA DIGITAL PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA DIGITAL PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA DIGITAL PCR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA DIGITAL PCR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA DIGITAL PCR MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA DIGITAL PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA DIGITAL PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA DIGITAL PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA DIGITAL PCR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE DIGITAL PCR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE DIGITAL PCR MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE DIGITAL PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE DIGITAL PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE DIGITAL PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE DIGITAL PCR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. MIDDLE EAST DIGITAL PCR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 96. MIDDLE EAST DIGITAL PCR MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 97. MIDDLE EAST DIGITAL PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST DIGITAL PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST DIGITAL PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST DIGITAL PCR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. AFRICA DIGITAL PCR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 102. AFRICA DIGITAL PCR MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 103. AFRICA DIGITAL PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 104. AFRICA DIGITAL PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA DIGITAL PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA DIGITAL PCR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL DIGITAL PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. ASEAN DIGITAL PCR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 109. ASEAN DIGITAL PCR MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 110. ASEAN DIGITAL PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 111. ASEAN DIGITAL PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. ASEAN DIGITAL PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. ASEAN DIGITAL PCR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. GCC DIGITAL PCR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 115. GCC DIGITAL PCR MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 116. GCC DIGITAL PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 117. GCC DIGITAL PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. GCC DIGITAL PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. GCC DIGITAL PCR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPEAN UNION DIGITAL PCR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPEAN UNION DIGITAL PCR MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPEAN UNION DIGITAL PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPEAN UNION DIGITAL PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPEAN UNION DIGITAL PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPEAN UNION DIGITAL PCR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. BRICS DIGITAL PCR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 127. BRICS DIGITAL PCR MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 128. BRICS DIGITAL PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 129. BRICS DIGITAL PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. BRICS DIGITAL PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. BRICS DIGITAL PCR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. G7 DIGITAL PCR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 133. G7 DIGITAL PCR MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 134. G7 DIGITAL PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 135. G7 DIGITAL PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. G7 DIGITAL PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. G7 DIGITAL PCR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. NATO DIGITAL PCR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 139. NATO DIGITAL PCR MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 140. NATO DIGITAL PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 141. NATO DIGITAL PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. NATO DIGITAL PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. NATO DIGITAL PCR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL DIGITAL PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. UNITED STATES DIGITAL PCR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 146. UNITED STATES DIGITAL PCR MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 147. UNITED STATES DIGITAL PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 148. UNITED STATES DIGITAL PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. UNITED STATES DIGITAL PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. UNITED STATES DIGITAL PCR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. CANADA DIGITAL PCR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 152. CANADA DIGITAL PCR MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 153. CANADA DIGITAL PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 154. CANADA DIGITAL PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. CANADA DIGITAL PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. CANADA DIGITAL PCR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. MEXICO DIGITAL PCR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 158. MEXICO DIGITAL PCR MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 159. MEXICO DIGITAL PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 160. MEXICO DIGITAL PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. MEXICO DIGITAL PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. MEXICO DIGITAL PCR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. BRAZIL DIGITAL PCR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 164. BRAZIL DIGITAL PCR MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 165. BRAZIL DIGITAL PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 166. BRAZIL DIGITAL PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. BRAZIL DIGITAL PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. BRAZIL DIGITAL PCR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. UNITED KINGDOM DIGITAL PCR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 170. UNITED KINGDOM DIGITAL PCR MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 171. UNITED KINGDOM DIGITAL PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED KINGDOM DIGITAL PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. UNITED KINGDOM DIGITAL PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. UNITED KINGDOM DIGITAL PCR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. GERMANY DIGITAL PCR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 176. GERMANY DIGITAL PCR MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 177. GERMANY DIGITAL PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 178. GERMANY DIGITAL PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. GERMANY DIGITAL PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. GERMANY DIGITAL PCR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. FRANCE DIGITAL PCR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 182. FRANCE DIGITAL PCR MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 183. FRANCE DIGITAL PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 184. FRANCE DIGITAL PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. FRANCE DIGITAL PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. FRANCE DIGITAL PCR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. RUSSIA DIGITAL PCR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 188. RUSSIA DIGITAL PCR MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 189. RUSSIA DIGITAL PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 190. RUSSIA DIGITAL PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. RUSSIA DIGITAL PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. RUSSIA DIGITAL PCR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 193. ITALY DIGITAL PCR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 194. ITALY DIGITAL PCR MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 195. ITALY DIGITAL PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 196. ITALY DIGITAL PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. ITALY DIGITAL PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. ITALY DIGITAL PCR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. SPAIN DIGITAL PCR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 200. SPAIN DIGITAL PCR MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 201. SPAIN DIGITAL PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 202. SPAIN DIGITAL PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. SPAIN DIGITAL PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. SPAIN DIGITAL PCR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA DIGITAL PCR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 206. CHINA DIGITAL PCR MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 207. CHINA DIGITAL PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 208. CHINA DIGITAL PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. CHINA DIGITAL PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 210. CHINA DIGITAL PCR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 211. INDIA DIGITAL PCR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 212. INDIA DIGITAL PCR MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 213. INDIA DIGITAL PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 214. INDIA DIGITAL PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. INDIA DIGITAL PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 216. INDIA DIGITAL PCR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 217. JAPAN DIGITAL PCR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 218. JAPAN DIGITAL PCR MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 219. JAPAN DIGITAL PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 220. JAPAN DIGITAL PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. JAPAN DIGITAL PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. JAPAN DIGITAL PCR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. AUSTRALIA DIGITAL PCR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 224. AUSTRALIA DIGITAL PCR MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 225. AUSTRALIA DIGITAL PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 226. AUSTRALIA DIGITAL PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. AUSTRALIA DIGITAL PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 228. AUSTRALIA DIGITAL PCR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. SOUTH KOREA DIGITAL PCR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 230. SOUTH KOREA DIGITAL PCR MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 231. SOUTH KOREA DIGITAL PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 232. SOUTH KOREA DIGITAL PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. SOUTH KOREA DIGITAL PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 234. SOUTH KOREA DIGITAL PCR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)